These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7168873)

  • 1. The classification of drugs on the basis of the drug-binding site on human serum albumin.
    Iwatsuru M; Nishigori H; Maruyama K
    Chem Pharm Bull (Tokyo); 1982 Dec; 30(12):4489-93. PubMed ID: 7168873
    [No Abstract]   [Full Text] [Related]  

  • 2. Classification of drugs on the basis of bilirubin-displacing effect on human serum albumin.
    Maruyama K; Harada S; Nishigori H; Iwatsuru M
    Chem Pharm Bull (Tokyo); 1984 Jun; 32(6):2414-20. PubMed ID: 6488410
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles.
    Sjöholm I; Ekman B; Kober A; Ljungstedt-Påhlman I; Seiving B; Sjödin T
    Mol Pharmacol; 1979 Nov; 16(3):767-77. PubMed ID: 530258
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug therapy. Binding of drugs to serum albumin (second of two parts).
    Koch-Weser J; Sellers EM
    N Engl J Med; 1976 Mar; 294(10):526-31. PubMed ID: 765821
    [No Abstract]   [Full Text] [Related]  

  • 5. Dependence of drug-protein binding parameters on human serum and albumin concentration.
    Brunner F; Zini R; Tillement JP
    J Pharm Pharmacol; 1983 Aug; 35(8):526-8. PubMed ID: 6137542
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of fatty acids on two specific drug binding sites on human serum albumin.
    Birkett DJ; Myers SP; Sudlow G
    Mol Pharmacol; 1977 Nov; 13(6):987-92. PubMed ID: 593269
    [No Abstract]   [Full Text] [Related]  

  • 7. The location of drug binding sites in human serum albumin.
    Fehske KJ; Müller WE; Wollert U
    Biochem Pharmacol; 1981 Apr; 30(7):687-92. PubMed ID: 7018498
    [No Abstract]   [Full Text] [Related]  

  • 8. New fluorescence probes for drug-albumin interaction studies.
    Goya S; Takadate A; Fujino H; Otagiri M; Uekama K
    Chem Pharm Bull (Tokyo); 1982 Apr; 30(4):1363-9. PubMed ID: 7105256
    [No Abstract]   [Full Text] [Related]  

  • 9. An in vitro model of drug-albumin interaction [proceedings].
    McElnay JC; Arcy PF
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():1P. PubMed ID: 22637
    [No Abstract]   [Full Text] [Related]  

  • 10. Binding of certain acidic drugs to human albumin: theoretical and practical estimation of fundamental parameters.
    Tillement JP; Zini R; d' Athis P; Vassent G
    Eur J Clin Pharmacol; 1974 Jul; 7(4):307-13. PubMed ID: 4850753
    [No Abstract]   [Full Text] [Related]  

  • 11. Circular dichroic examination of the interaction of some planar acidic drugs with tryptophan-modified human serum albumin.
    Vallner JJ; Perrin JH
    J Pharm Pharmacol; 1981 Nov; 33(11):697-700. PubMed ID: 6171635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid method for the estimation of drug-albumin affinity constants in human plasma.
    Solomon HM; Thomas GB
    Clin Pharmacol Ther; 1971; 12(3):445-8. PubMed ID: 5567799
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical pharmacology: plasma protein binding of drugs.
    Lindup WE; Orme MC
    Br Med J (Clin Res Ed); 1981 Jan; 282(6259):212-4. PubMed ID: 6779954
    [No Abstract]   [Full Text] [Related]  

  • 14. Binding of drugs to serum albumin (first of two parts).
    Koch-Weser J; Sellers EM
    N Engl J Med; 1976 Feb; 294(6):311-6. PubMed ID: 1107839
    [No Abstract]   [Full Text] [Related]  

  • 15. N-bromosuccinimide-oxidized human serum albumin as a tool for the determination of drug binding sites of human serum albumin.
    Sakamoto H; Nagata I; Kikuchi K; Aida M; Irie M
    Chem Pharm Bull (Tokyo); 1983 Mar; 31(3):971-8. PubMed ID: 6883610
    [No Abstract]   [Full Text] [Related]  

  • 16. An analysis of the effect of hypoalbuminemia on the amount of free drug in plasma for drugs bound at two sets of sites.
    Wosilait WD
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):681-8. PubMed ID: 4456500
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum albumin--a non-saturable carrier.
    Brodersen R; Honoré B; Larsen FG
    Acta Pharmacol Toxicol (Copenh); 1984 Feb; 54(2):129-33. PubMed ID: 6711320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug binding in human serum albumin as assayed by diafiltration and fluorimetry.
    Geddes R; White PM
    Biochem Pharmacol; 1979 Aug; 28(15):2285-8. PubMed ID: 497010
    [No Abstract]   [Full Text] [Related]  

  • 19. Variation in the heats of reaction of drugs and albumin with the source and pretreatment of the albumin.
    Hardee GE; Otagiri M; Perrin JH
    J Pharm Pharmacol; 1979 Sep; 31(9):656. PubMed ID: 41083
    [No Abstract]   [Full Text] [Related]  

  • 20. Microcalorimetric investigations of pharmaceutical complexes II. Drug-albumin interactions.
    Otagiri M; Hardee GE; Perrin JH
    Biochem Pharmacol; 1978 May; 27(9):1401-4. PubMed ID: 697945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.